Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

CUSIP: 98422T100

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 6 signals
Share change
-894,481
SEC-reported price per share
$2.92
Indexed holders
29
Value change
-$3,647,986
Number of buys
12
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
6,426,426

Security key

98422T100

Report period

Q2 2022

Indexed institutions

29

Top holders

10

Ownership snapshot

Top reported holders of XLO - Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bain Capital Life Science...
Disclosed value leader
Bain Capital Life Science...
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F 3/4/5 Highest disclosed value: $19,834,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $19.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.
Disclosed position value Top 5
Bain Capital Life Sciences Invest... $19.83M
Rock Springs Capital Management LP $8.42M
SV7 Impact Medicine Fund LP $2.68M
James E. Flynn $1.9M
TAKEDA PHARMACEUTICAL CO LTD $1.22M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bain Capital Life Sciences Investors, LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$19,834,000
2,805,413 shares
— 31 Mar 2022
Rock Springs Capital Management LP
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$8,421,000
1,191,094 shares
— 31 Mar 2022
SV7 Impact Medicine Fund LP
3/4/5
10%+ Owner
—
denominator unverified
$2,678,630
3,227,264 shares
— 26 Oct 2021
James E. Flynn
3/4/5
Possible Member of 10% Group, 10%+ Owner
—
denominator unverified
$1,898,994
2,287,944 shares
— 26 Oct 2021
TAKEDA PHARMACEUTICAL CO LTD
3/4/5
10%+ Owner
—
denominator unverified
$1,224,350
1,475,121 shares
— 26 Oct 2021
RiverVest Venture Fund IV, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,196,399
1,441,444 shares
— 26 Oct 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
29
Shares
17,880,380
Indexed holders
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 indexed holders
41
Q2 2022 indexed holders
29
Indexed holder difference
-12
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .